{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:50:10Z","timestamp":1785894610737,"version":"3.56.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020953","name":"Taiwan Centers for Disease Control","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020953","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jfma.2026.06.042","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:50:12Z","timestamp":1782503412000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of COVID-19 antiviral interventions in Taiwan, 2022\u20132025: Insights from public health policy"],"prefix":"10.1016","author":[{"given":"Hsin-Yi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7820","key":"10.1016\/j.jfma.2026.06.042_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","article-title":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","volume":"584","author":"Flaxman","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2026.06.042_bib4","volume":"vol. 33","year":"2024"},{"issue":"10317","key":"10.1016\/j.jfma.2026.06.042_bib5","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.jfma.2026.06.042_bib7","first-page":"268","article-title":"SARS-CoV-2 seroepidemiological survey and long-term trend analysis in Taiwan","volume":"39","author":"Lee","year":"2023","journal-title":"Taiwan Epidemiol Bull"},{"key":"10.1016\/j.jfma.2026.06.042_bib28","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.05032","article-title":"Low antiviral uptake of nirmatrelvir\/ritonavir and molnupiravir in adult patients with COVID-19 in Taiwan in 2022","volume":"14","author":"Wang","year":"2024","journal-title":"J Glob Health"},{"key":"10.1016\/j.jfma.2026.06.042_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.15585\/mmwr.mm7339a3","article-title":"Differences in COVID-19 outpatient antiviral treatment among adults aged \u226565 Years by Age Group \u2014 national patient-centered clinical research network, United States, April 2022\u2013September 2023","volume":"73","author":"Quinlan","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jfma.2026.06.042_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000276","article-title":"Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY","volume":"2","author":"Green","year":"2023","journal-title":"BMJ Medicine"},{"issue":"3","key":"10.1016\/j.jfma.2026.06.042_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3201\/eid3003.230893","article-title":"Population-Based evaluation of vaccine effectiveness against SARS-CoV-2 infection, severe illness, and death, Taiwan","volume":"30","author":"Lee","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jfma.2026.06.042_bib33","article-title":"COVID-19 epidemic weekly report","volume":"30","year":"2025","journal-title":"Met Week"},{"issue":"9","key":"10.1016\/j.jfma.2026.06.042_bib36","doi-asserted-by":"crossref","first-page":"ofaf553","DOI":"10.1093\/ofid\/ofaf553","article-title":"Real-world effectiveness of nirmatrelvir-ritonavir against severe outcomes of COVID-19 in Taiwan: a nationwide population-based cohort study","volume":"12","author":"Kuo","year":"2025","journal-title":"Open Forum Infect Dis"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626006996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626006996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:26:58Z","timestamp":1785893218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626006996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S0929664626006996"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.06.042","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of COVID-19 antiviral interventions in Taiwan, 2022\u20132025: Insights from public health policy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}